Literature DB >> 19902220

Comparison of temporal lobectomies of children and adults with intractable temporal lobe epilepsy.

Yun Jin Lee1, Hoon-Chul Kang, Sun Joon Bae, Heung Dong Kim, Jeong Tae Kim, Byung In Lee, Kyoung Heo, Jin Woo Jang, Dong Seok Kim, Tae Seung Kim, Joon Soo Lee.   

Abstract

INTRODUCTION: The aim of the study was to assess the difference in clinical characteristics and postsurgical outcomes between children and adults who have undergone temporal lobectomy (TL).
MATERIALS AND METHODS: We retrospectively reviewed the medical records of 52 patients who had undergone TL between 2006 and 2008. Nineteen patients were classified as children (<or=18 years old), and 33 patients were classified as adults (>18 years old) according to the age when TL had been performed.
RESULTS: Twelve of 19 (63.2%) children and 24 of 33 (72.7%) adults became seizure free. Rapid secondary generalization such as generalized tonic or tonic-clonic seizures showed a tendency to be more prominent in children (four of 19, 21.1%) than in adults (three of 33, 9.1%). Patients in childhood had significantly more multifocal discharges on interictal electroencephalography (EEG) (42.1%) compared to adults (15.2%, p = 0.014). The mean extent of surgical excision was 5.0 cm in children and 4.1 cm in adults (p = 0.001). The incidence of hippocampal sclerosis, the most common pathologic finding in the two groups, was 57.9% (11 of 19) in children and 78.8% (26 of 33) in adults. Malformations of cortical development were significantly more frequent in children (nine of 19, 47.4%) than in adults (seven of 33, 21.2%). Dual pathology was found in 31.6% of children and in 12.1% of adults. The intelligence quotient and memory quotient values in children with temporal lobe resection remained nearly steady during follow-up period without significant decline.
CONCLUSION: Patients undergoing TL during childhood compared to during adulthood had distinctively different interictal EEG, resectional extents, and pathologic findings.

Entities:  

Mesh:

Year:  2009        PMID: 19902220     DOI: 10.1007/s00381-009-1015-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  18 in total

1.  Prognostic factors in anterior temporal lobe resections for mesial temporal lobe epilepsy: multivariate analysis.

Authors:  S W Jeong; S K Lee; K K Kim; H Kim; J Y Kim; C K Chung
Journal:  Epilepsia       Date:  1999-12       Impact factor: 5.864

Review 2.  Treatment options and paradigms in childhood temporal lobe epilepsy.

Authors:  Amit Ray; Elaine Wyllie
Journal:  Expert Rev Neurother       Date:  2005-11       Impact factor: 4.618

Review 3.  Complex partial seizures of childhood onset. A five-year follow-up study.

Authors:  P Kotagal; A D Rothner; G Erenberg; R P Cruse; E Wyllie
Journal:  Arch Neurol       Date:  1987-11

4.  Temporal lobe epilepsy due to hippocampal sclerosis in pediatric candidates for epilepsy surgery.

Authors:  A Mohamed; E Wyllie; P Ruggieri; P Kotagal; T Babb; A Hilbig; C Wylie; Z Ying; S Staugaitis; I Najm; J Bulacio; N Foldvary; H Lüders; W Bingaman
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

5.  Temporal lobe epilepsy surgery in children and adolescents: clinical characteristics and post-surgical outcome.

Authors:  Vera Cristina Terra-Bustamante; Luciana M Inuzuca; Regina M F Fernandes; Sandra Funayama; Sara Escorsi-Rosset; Lauro Wichert-Ana; Antonio C Santos; David Araujo; Helio R Machado; Americo C Sakamoto
Journal:  Seizure       Date:  2005-06       Impact factor: 3.184

Review 6.  Early surgery for epilepsy: redefining candidacy.

Authors:  T J Resnick; M Duchowny; P Jayakar
Journal:  J Child Neurol       Date:  1994-10       Impact factor: 1.987

7.  Surgical outcome of patients with mesial temporal lobe epilepsy related to hippocampal sclerosis.

Authors:  Ciğdem Ozkara; Mustafa Uzan; Gülçin Benbir; Naz Yeni; Büge Oz; Lütfü Hanoğlu; Naci Karaağac; Emin Ozyurt
Journal:  Epilepsia       Date:  2008-01-18       Impact factor: 5.864

8.  Surgery for medically intractable temporal lobe epilepsy during early life.

Authors:  Bruno Maton; Prasanna Jayakar; Trevor Resnick; Glenn Morrison; John Ragheb; Michael Duchowny
Journal:  Epilepsia       Date:  2007-09-12       Impact factor: 5.864

9.  Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence.

Authors:  Anne M McIntosh; Renate M Kalnins; L Anne Mitchell; Gavin C A Fabinyi; Regula S Briellmann; Samuel F Berkovic
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

10.  Periventricular and subcortical nodular heterotopia. A study of 33 patients.

Authors:  F Dubeau; D Tampieri; N Lee; E Andermann; S Carpenter; R Leblanc; A Olivier; R Radtke; J G Villemure; F Andermann
Journal:  Brain       Date:  1995-10       Impact factor: 13.501

View more
  6 in total

1.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

2.  Temporal lobe epilepsy surgery in children versus adults: from etiologies to outcomes.

Authors:  Yun-Jin Lee; Joon Soo Lee
Journal:  Korean J Pediatr       Date:  2013-07-19

3.  Surgery for childhood epilepsy.

Authors:  Sita Jayalakshmi; Manas Panigrahi; Subrat Kumar Nanda; Rammohan Vadapalli
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

4.  Temporal lobe epilepsy in children.

Authors:  Katherine C Nickels; Lily C Wong-Kisiel; Brian D Moseley; Elaine C Wirrell
Journal:  Epilepsy Res Treat       Date:  2011-10-20

5.  Language mapping in temporal lobe epilepsy in children: special considerations.

Authors:  Sandrine de Ribaupierre; An Wang; Susan Hayman-Abello
Journal:  Epilepsy Res Treat       Date:  2012-02-09

6.  Automatic Identification of Interictal Epileptiform Discharges in Secondary Generalized Epilepsy.

Authors:  Won-Du Chang; Ho-Seung Cha; Chany Lee; Hoon-Chul Kang; Chang-Hwan Im
Journal:  Comput Math Methods Med       Date:  2016-06-09       Impact factor: 2.238

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.